
NeurAxis, Inc. – NASDAQ:NRXS
NeurAxis stock price today
NeurAxis stock price monthly change
NeurAxis stock price quarterly change
NeurAxis stock price yearly change
NeurAxis key metrics
Market Cap | 16.93M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -3.51 |
Revenue | 2.30M |
EBITDA | -7.77M |
Income | -14.57M |
Revenue Q/Q | -19.68% |
Revenue Y/Y | -15.37% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -337.78% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNeurAxis stock price history
NeurAxis stock forecast
NeurAxis financial statements
Jun 2023 | 646.02K | -2.23M | -346.06% |
---|---|---|---|
Sep 2023 | 477.46K | -4.90M | -1027.18% |
Dec 2023 | 531.45K | -5.31M | -999.76% |
Mar 2024 | 646.63K | -2.12M | -327.95% |
2023-11-20 | -0.17 | -1.06 |
---|
Jun 2023 | 1539691 | 11.52M | 748.35% |
---|---|---|---|
Sep 2023 | 1235918 | 2.29M | 185.85% |
Dec 2023 | 509498 | 1.91M | 375.42% |
Mar 2024 | 945729 | 4.13M | 436.72% |
Jun 2023 | -625.22K | -5.45K | 636.66K |
---|---|---|---|
Sep 2023 | -2.81M | -42.67K | 3.56M |
Dec 2023 | -2.62M | -16.04K | 1.96M |
Mar 2024 | -1.33M | -14.72K | 1.35M |
NeurAxis alternative data
Dec 2023 | 17 |
---|---|
Jan 2024 | 17 |
Feb 2024 | 17 |
Mar 2024 | 17 |
Apr 2024 | 17 |
May 2024 | 19 |
Jun 2024 | 19 |
Jul 2024 | 19 |
NeurAxis other data
Quarter | Transcript |
---|---|
Q1 2024 22 May 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 9 Apr 2024 | Q4 2023 Earnings Call Transcript |
-
What's the price of NeurAxis stock today?
One share of NeurAxis stock can currently be purchased for approximately $2.37.
-
When is NeurAxis's next earnings date?
Unfortunately, NeurAxis's (NRXS) next earnings date is currently unknown.
-
Does NeurAxis pay dividends?
No, NeurAxis does not pay dividends.
-
How much money does NeurAxis make?
NeurAxis has a market capitalization of 16.93M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.37% to 2.46M US dollars. NeurAxis made a loss 14.63M US dollars in net income (profit) last year or -$1.06 on an earnings per share basis.
-
What is NeurAxis's stock symbol?
NeurAxis, Inc. is traded on the NASDAQ under the ticker symbol "NRXS".
-
What is NeurAxis's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NeurAxis?
Shares of NeurAxis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does NeurAxis have?
As Jul 2024, NeurAxis employs 19 workers, which is 12% more then previous quarter.
-
When NeurAxis went public?
NeurAxis, Inc. is publicly traded company for more then 2 years since IPO on 9 Aug 2023.
-
What is NeurAxis's official website?
The official website for NeurAxis is neuraxis.com.
-
Where are NeurAxis's headquarters?
NeurAxis is headquartered at 11550 North Meridian Street, Carmel, IN.
-
How can i contact NeurAxis?
NeurAxis's mailing address is 11550 North Meridian Street, Carmel, IN and company can be reached via phone at +81 26890791.
NeurAxis company profile:

NeurAxis, Inc.
neuraxis.comNASDAQ
19
Biotechnology
Healthcare
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Carmel, IN 46032
CIK: 0001933567
ISIN: US64134X2018
CUSIP: 64134X201